MediFind

Find a Doctor

Marco Metra

University Of Brescia
Cardiology
Male

Bio


Marco Metra is a Cardiologist in Brescia, Italy. They have been an author on 632 peer reviewed articles and participated in 1 clinical trials in the past 15 years. Dr. Metra's top three areas of expertise are Heart Failure, Cardiomyopathy, and Stroke.

Contact

Brescia, IT

Latest Research


Latest Advance
Study
  • Condition: Severe COVID-19 Pneumonia with Hyperinflammatory Syndrome (HIS) and Acute Respiratory Failure
  • Journal: Autoimmunity reviews
  • Treatment Used: Tocilizumab (TCZ)
  • Number of Patients: 100
  • Published —
This study analyzed patients with confirmed COVID-19 pneumonia and acute respiratory distress syndrome (ARDS) requiring ventilatory support to determine whether intravenous administration of tocilizumab (TCZ), a monoclonal antibody that targets the interleukin 6 receptor, was associated with improved outcome.
Latest Advance
Study
  • Condition: Patients with Heart Failure and Reduced Ejection Fraction (HFrEF)
  • Journal: Clinical research in cardiology : official journal of the German Cardiac Society
  • Treatment Used: Loop Diuretics
  • Number of Patients: 2338
  • Published —
This study determined whether loop diuretics might dampen uptitration of inhibitors in patients with heart failure and reduced ejection fraction (HFrEF).
Latest Advance
Study
  • Condition: Acute heart failure
  • Journal: European journal of heart failure
  • Treatment Used: Serelaxin
  • Number of Patients: 11359
  • Published —
The study researched the effects of Serelaxin for patients admitted for acute heart failure.
Latest Advance
Study
  • Condition: Acute Heart Failure
  • Journal: The New England journal of medicine
  • Treatment Used: Serelaxin
  • Number of Patients: 6545
  • Published —
The study aimed to determine the effect of Serelaxin in treating acute heart failure.
Latest Advance
Study
  • Condition: Functional Mitral Regurgitation
  • Journal: European journal of heart failure
  • Treatment Used: Left Ventricular Reverse Remodelling for MitraClip Therapy
  • Number of Patients: 184
  • Published —
This study explored whether left ventricular reverse remodelling (LVRR) is a predictor of outcomes in patients with functional mitral regurgitation (FMR), or leakage of blood backward through the mitral valve each time the left ventricle contracts, undergoing MitraClip procedure.
Latest Advance
Study
  • Condition: Acute Heart Failure (HF) and Cardiogenic Shock
  • Journal: European heart journal
  • Treatment Used: Novel Inotropic Agents
  • Number of Patients: 0
  • Published —
This article reviews the pathophysiological basis of systolic dysfunction in patients with heart failure (HF) and the mechanisms through which different inotropic agents improve cardiac function.
Latest Advance
Study
  • Condition: Chronic Heart Failure and Atrial Fibrillation
  • Journal: International journal of cardiology
  • Treatment Used: Beta Blockers
  • Number of Patients: 958
  • Published —
This study tested the safety and efficacy of treating patients with chronic heart failure and permanent atrial fibrillation with beta blockers as the validity of their effectiveness has been questioned.

Clinical Trials


This doctor has not participated in any recent clinical trials.

All Publications
View All


Publication
Study
  • Journal: Journal of cardiovascular medicine (Hagerstown, Md.)
  • Published —
Coronavirus disease 2019 and cardiovascular implications.
Publication
Study
  • Journal: Journal of cardiovascular medicine (Hagerstown, Md.)
  • Published —
Transcatheter therapies for tricuspid valve regurgitation.

Contact

Brescia, IT

Insurance

Contact them to find out if they accept your insurance plan.